Business
Press Release Jul 04 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated July 04, 2023, titled "Stelis Biopharma enters into a binding term sheet with Syngene International Limited to divest its Unit 3 multi-modal facility for a gross consideration of INR 7,020 million".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated July 04, 2023, titled "Stelis Biopharma enters into a binding term sheet with Syngene International Limited to divest its Unit 3 multi-modal facility for a gross consideration of INR 7,020 million". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd